$AIRG
AIRGAIN INC

2024 Q2 Form 10-Q Financial Statement

#000095017024055887 Filed on May 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q4
Revenue $15.18M $14.23M $10.07M
YoY Change -4.08% -13.46% -49.37%
Cost Of Revenue $9.036M $8.655M $7.140M
YoY Change -5.39% -14.53% -49.03%
Gross Profit $6.148M $5.576M $2.930M
YoY Change -2.09% -11.74% -50.17%
Gross Profit Margin 40.49% 39.18% 29.1%
Selling, General & Admin $5.537M $5.085M $5.250M
YoY Change -6.17% -23.64% -24.1%
% of Gross Profit 90.06% 91.19% 179.18%
Research & Development $3.116M $3.120M $3.168M
YoY Change 20.31% 27.4% 41.43%
% of Gross Profit 50.68% 55.95% 108.12%
Depreciation & Amortization $100.0K $100.0K $903.0K
YoY Change -50.0% -50.0% -2.9%
% of Gross Profit 1.63% 1.79% 30.82%
Operating Expenses $8.653M $8.205M $8.418M
YoY Change 1.91% -9.91% -8.07%
Operating Profit -$2.505M -$2.629M -$5.488M
YoY Change 13.25% -5.77% 67.47%
Interest Expense $27.00K $26.00K $41.00K
YoY Change 68.75% 44.44% 57.69%
% of Operating Profit
Other Income/Expense, Net $26.00K $34.00K $7.000K
YoY Change -620.0% 142.86% -143.75%
Pretax Income -$2.479M -$2.595M -$5.440M
YoY Change 12.32% -6.52% 66.51%
Income Tax $34.00K -$140.0K $44.00K
% Of Pretax Income
Net Earnings -$2.513M -$2.455M -$5.484M
YoY Change 13.97% -14.1% 70.31%
Net Earnings / Revenue -16.55% -17.25% -54.46%
Basic Earnings Per Share -$0.23 -$0.23
Diluted Earnings Per Share -$0.23 -$0.23 -$0.52
COMMON SHARES
Basic Shares Outstanding 10.78M 10.50M 10.44M
Diluted Shares Outstanding 10.94M 10.53M

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.416M $7.169M $7.881M
YoY Change -9.21% -27.14% -33.79%
Cash & Equivalents $8.416M $7.169M $7.881M
Short-Term Investments
Other Short-Term Assets $1.109M $1.419M $1.422M
YoY Change -34.3% -17.93% -37.74%
Inventory $3.144M $2.588M $2.403M
Prepaid Expenses
Receivables $8.642M $9.644M $7.375M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $21.31M $20.82M $19.08M
YoY Change -12.59% -13.96% -29.73%
LONG-TERM ASSETS
Property, Plant & Equipment $2.220M $2.305M $2.507M
YoY Change -12.74% -14.09% -49.68%
Goodwill $10.85M $10.85M $10.85M
YoY Change 0.0% 0.0% 0.0%
Intangibles $6.751M $7.493M $8.234M
YoY Change -30.53% -28.37% -26.5%
Long-Term Investments
YoY Change
Other Assets $164.0K $155.0K $170.0K
YoY Change -21.9% -28.24% -21.3%
Total Long-Term Assets $21.13M $21.98M $23.15M
YoY Change -15.94% -16.2% -15.04%
TOTAL ASSETS
Total Short-Term Assets $21.31M $20.82M $19.08M
Total Long-Term Assets $21.13M $21.98M $23.15M
Total Assets $42.44M $42.80M $42.23M
YoY Change -14.29% -15.12% -22.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.844M $7.156M $6.472M
YoY Change 3.27% 6.11% -0.54%
Accrued Expenses $4.277M $4.225M $2.971M
YoY Change 111.0% 22.39% -53.53%
Deferred Revenue $30.20K $10.60M $17.00M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $10.31M $11.65M $9.991M
YoY Change -8.03% 9.3% -22.55%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $370.0K $476.0K $674.0K
YoY Change -65.74% -63.97% -56.12%
Total Long-Term Liabilities $370.0K $476.0K $674.0K
YoY Change -65.74% -63.97% -56.12%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.31M $11.65M $9.991M
Total Long-Term Liabilities $370.0K $476.0K $674.0K
Total Liabilities $10.85M $12.29M $10.82M
YoY Change -12.76% 1.34% -25.79%
SHAREHOLDERS EQUITY
Retained Earnings -$83.49M -$80.98M -$78.52M
YoY Change 17.33% 17.44% 18.8%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $5.364M $5.364M $5.364M
YoY Change 0.0% 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity $31.59M $30.51M $31.41M
YoY Change
Total Liabilities & Shareholders Equity $42.44M $42.80M $42.23M
YoY Change -14.29% -15.12% -22.37%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income -$2.513M -$2.455M -$5.484M
YoY Change 13.97% -14.1% 70.31%
Depreciation, Depletion And Amortization $100.0K $100.0K $903.0K
YoY Change -50.0% -50.0% -2.9%
Cash From Operating Activities -$1.203M -$1.119M -$1.937M
YoY Change 111.05% -21.97% -181.97%
INVESTING ACTIVITIES
Capital Expenditures $90.00K $60.00K $174.0K
YoY Change 500.0% -32.58% 34.88%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$90.00K -$60.00K -$174.0K
YoY Change 500.0% -32.58% 38.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.543M 469.0K 2.000K
YoY Change 15793.75% -186.69% -99.58%
NET CHANGE
Cash From Operating Activities -1.203M -1.119M -1.937M
Cash From Investing Activities -90.00K -60.00K -174.0K
Cash From Financing Activities 2.543M 469.0K 2.000K
Net Change In Cash 1.250M -712.0K -2.111M
YoY Change -319.68% -65.5% -177.81%
FREE CASH FLOW
Cash From Operating Activities -$1.203M -$1.119M -$1.937M
Capital Expenditures $90.00K $60.00K $174.0K
Free Cash Flow -$1.293M -$1.179M -$2.111M
YoY Change 121.03% -22.59% -194.49%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001272842
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 airg Amortization Of Prepaid Assets
AmortizationOfPrepaidAssets
CY2023Q1 airg Accrual Of Property And Equipment
AccrualOfPropertyAndEquipment
CY2023Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
CY2023Q1 us-gaap Income Tax Refunds Discontinued Operations
IncomeTaxRefundsDiscontinuedOperations
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
CY2024Q1 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2025-12-31
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-37851
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
AIRGAIN, INC.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
95-4523882
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
3611 Valley Centre Drive
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 150
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92130
CY2024Q1 dei City Area Code
CityAreaCode
760
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
579-0200
CY2024Q1 dei Security12b Title
Security12bTitle
Common stock, par value $0.0001 per share
CY2024Q1 dei Trading Symbol
TradingSymbol
AIRG
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10777426
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7169000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7881000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9644000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7375000
CY2024Q1 us-gaap Inventory Net
InventoryNet
2588000
CY2023Q4 us-gaap Inventory Net
InventoryNet
2403000
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1419000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1422000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
20820000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
19081000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2305000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2507000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1180000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1392000
CY2024Q1 us-gaap Goodwill
Goodwill
10845000
CY2023Q4 us-gaap Goodwill
Goodwill
10845000
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7493000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8234000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
155000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
170000
CY2024Q1 us-gaap Assets
Assets
42798000
CY2023Q4 us-gaap Assets
Assets
42229000
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
7156000
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2866000
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2927000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3793000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6472000
CY2024Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
799000
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
728000
CY2024Q1 airg Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
2848000
CY2023Q4 airg Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
1926000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
848000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
865000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
11651000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9991000
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
158000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
151000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
476000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
674000
CY2024Q1 us-gaap Liabilities
Liabilities
12285000
CY2023Q4 us-gaap Liabilities
Liabilities
10816000
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11302000
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10761000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11010000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10469000
CY2024Q1 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
116852000
CY2023Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
115295000
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
541000
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
541000
CY2024Q1 us-gaap Treasury Stock Value
TreasuryStockValue
5364000
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
5364000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-80976000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-78521000
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
30513000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
31413000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
42798000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
42229000
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14231000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16444000
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
8655000
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
10126000
CY2024Q1 us-gaap Gross Profit
GrossProfit
5576000
CY2023Q1 us-gaap Gross Profit
GrossProfit
6318000
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3120000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2449000
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2158000
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
8205000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
9108000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2629000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2790000
CY2024Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
26000
CY2023Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
18000
CY2024Q1 airg Other Income Expense
OtherIncomeExpense
8000
CY2023Q1 airg Other Income Expense
OtherIncomeExpense
-4000
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
34000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
14000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2595000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2776000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-140000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
82000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2455000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2858000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10532000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10266000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10532000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10266000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2455000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2858000
CY2024Q1 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-2000
CY2023Q1 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
0
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2457000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2858000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
31413000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2455000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1087000
CY2024Q1 airg Common Stock Withheld Related To Net Share Settlement Of Equity Awards
CommonStockWithheldRelatedToNetShareSettlementOfEquityAwards
-94000
CY2024Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
76000
CY2024Q1 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-2000
CY2024Q1 airg Common Stock Issued In Connection With At The Market Offerings Value
CommonStockIssuedInConnectionWithAtTheMarketOfferingsValue
488000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
30513000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
39825000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2858000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1874000
CY2023Q1 airg Common Stock Withheld Related To Net Share Settlement Of Equity Awards
CommonStockWithheldRelatedToNetShareSettlementOfEquityAwards
-678000
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
137000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
38300000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-2455000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-2858000
CY2024Q1 us-gaap Depreciation
Depreciation
145000
CY2023Q1 us-gaap Depreciation
Depreciation
157000
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
742000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
743000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1046000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
981000
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
7000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
3000
CY2024Q1 airg Amortization Of Prepaid Assets
AmortizationOfPrepaidAssets
132000
CY2024Q1 airg Accrual Of Property And Equipment
AccrualOfPropertyAndEquipment
-15000
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2269000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-593000
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
185000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
255000
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-555000
CY2024Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-15000
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
684000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
250000
CY2024Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
72000
CY2023Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1109000
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
963000
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-459000
CY2024Q1 airg Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-4000
CY2023Q1 airg Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-35000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1119000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1434000
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
60000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
89000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-60000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-89000
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
488000
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
95000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
678000
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
76000
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
137000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
469000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-541000
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-712000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2064000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7976000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12078000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7264000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10014000
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
7000
CY2024Q1 us-gaap Income Tax Refunds Discontinued Operations
IncomeTaxRefundsDiscontinuedOperations
50000
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
11000
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
13000
CY2024Q1 airg Offering Costs Charged Against Proceeds From Sale Of Common Stock
OfferingCostsChargedAgainstProceedsFromSaleOfCommonStock
164000
CY2023Q1 airg Offering Costs Charged Against Proceeds From Sale Of Common Stock
OfferingCostsChargedAgainstProceedsFromSaleOfCommonStock
0
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7169000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9839000
CY2024Q1 us-gaap Restricted Cash
RestrictedCash
95000
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
175000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7264000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10014000
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p>
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
20000
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
100000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2455000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2858000
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10532000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10266000
CY2024Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10532000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10266000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2327000
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2224000
CY2024Q1 us-gaap Cash
Cash
6846000
CY2023Q4 us-gaap Cash
Cash
7581000
CY2024Q1 airg Cash And Cash Equivalents At Carrying Value Available And Available For Sale Debt Securities Amortized Cost Basis
CashAndCashEquivalentsAtCarryingValueAvailableAndAvailableForSaleDebtSecuritiesAmortizedCostBasis
7169000
CY2023Q4 airg Cash And Cash Equivalents At Carrying Value Available And Available For Sale Debt Securities Amortized Cost Basis
CashAndCashEquivalentsAtCarryingValueAvailableAndAvailableForSaleDebtSecuritiesAmortizedCostBasis
7881000
CY2024Q1 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
95000
CY2023Q4 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
95000
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
40000
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
40000
CY2024Q1 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
55000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
55000
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7364000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7557000
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5059000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5050000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2305000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2507000
CY2024Q1 us-gaap Depreciation
Depreciation
100000
CY2023Q1 us-gaap Depreciation
Depreciation
200000
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
20095000
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
12602000
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7493000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
20095000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
11861000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8234000
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
2226000
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2958000
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
557000
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
356000
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1396000
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
7493000
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
700000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
700000
CY2024Q1 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2023Q1 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2024Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1116000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1031000
CY2024Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
0
CY2023Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
339000
CY2024Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
47000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
145000
CY2024Q1 airg Advanced Payments From Contract Manufacturers
AdvancedPaymentsFromContractManufacturers
11000
CY2023Q4 airg Advanced Payments From Contract Manufacturers
AdvancedPaymentsFromContractManufacturers
0
CY2024Q1 airg Contract Liabilities Current
ContractLiabilitiesCurrent
0
CY2023Q4 airg Contract Liabilities Current
ContractLiabilitiesCurrent
17000
CY2024Q1 airg Goods Received Not Invoiced
GoodsReceivedNotInvoiced
1404000
CY2023Q4 airg Goods Received Not Invoiced
GoodsReceivedNotInvoiced
185000
CY2024Q1 us-gaap Other Liabilities
OtherLiabilities
270000
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
209000
CY2024Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
2848000
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1926000
CY2024Q1 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
5 years
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.038
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.038
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y7M6D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y9M18D
CY2024Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
29000
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
22000
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
300000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
674000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
687000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1361000
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
40000
CY2024Q1 airg Unrealized Translation Gain
UnrealizedTranslationGain
3000
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1324000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
848000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
476000
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.054
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.029
CY2024Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
14600000
CY2023Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
4326000
CY2022Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
4083000
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
541000
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
541000
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1046000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
981000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2104000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.2
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y2M12D
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
329000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
403000
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.07
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
13000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
6.8
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2494000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.39
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y7M6D
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding
1051000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1609000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
11.05
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y2M12D
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
552000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2494000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
9.39
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y7M6D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
1051000
CY2023Q4 airg Severance And Exit Costs1
SeveranceAndExitCosts1
50000
CY2024Q1 airg Accrued Expense Of Severanc Costs
AccruedExpenseOfSeverancCosts
0
CY2024Q1 airg Payment Of Severance Costs
PaymentOfSeveranceCosts
-50000
CY2024Q1 airg Severance And Exit Costs1
SeveranceAndExitCosts1
0
CY2024Q1 airg Accrual Warranty Expense
AccrualWarrantyExpense
100000
CY2023 airg Accrual Warranty Expense
AccrualWarrantyExpense
100000
CY2024Q1 us-gaap Noncurrent Assets
NoncurrentAssets
2305000
CY2023Q4 us-gaap Noncurrent Assets
NoncurrentAssets
2507000
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14231000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16444000
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14231000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16444000
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
14231000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16444000
CY2024Q1 us-gaap Contract With Customer Right To Recover Product
ContractWithCustomerRightToRecoverProduct
100000
CY2023Q4 us-gaap Contract With Customer Right To Recover Product
ContractWithCustomerRightToRecoverProduct
100000
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
10600000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
17000000
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
400000
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 airg Rule10 B51 Arr Modified Flag
Rule10B51ArrModifiedFlag
false
CY2024Q1 airg Non Rule10 B51 Arr Modified Flag
NonRule10B51ArrModifiedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-055887-index-headers.html Edgar Link pending
0000950170-24-055887-index.html Edgar Link pending
0000950170-24-055887.txt Edgar Link pending
0000950170-24-055887-xbrl.zip Edgar Link pending
airg-20240331.htm Edgar Link pending
airg-20240331.xsd Edgar Link pending
airg-ex31_1.htm Edgar Link pending
airg-ex31_2.htm Edgar Link pending
airg-ex32_1.htm Edgar Link pending
airg-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
airg-20240331_htm.xml Edgar Link completed
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable